Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Aumseqa 55 mg filmom obalené tablety

Code 2959F
MA number EU/1/25/2006/001
Product Form: tbl flm 60x55 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: SFL Pharmaceuticals Deutschland GmbH, Germany
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB11 Aumolertinib
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 12.02.2026
Validity: 12.02.2031
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 12.03.2026
eu-flag.png sk-flag.png